oxaliplatinum
PolandDrugs containing this active substance
-
The medicinal product is used in the treatment of colorectal cancer after tumor resection or in the treatment of metastatic cancer. It is administered in combination with other anticancer drugs.
Form: solution for infusion, concentrate
Active substance Dosage oxaliplatinum 5 mg/ml ATC: L01XA03
Manufacturer: Ebewe Pharma Ges.m.b.H Nfg. KG Fareva Unterach GmbH Salutas Pharma GmbH
-
The medicinal product is used in the treatment of advanced colorectal cancer (especially after removal of the primary tumor), colon cancer, and rectal cancer with metastases. It is administered in combination with other anticancer drugs.
Form: solution for infusion, concentrate
Active substance Dosage oxaliplatinum 5 mg/ml ATC: L01XA03
Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmacêutica, S.A.
-
The medicinal product is used in the treatment of colorectal cancer, including colon and rectal cancer (both in stage III after tumor removal and in cases of metastasis). It is used in combination with other anticancer drugs.
Form: solution for infusion, concentrate
Active substance Dosage oxaliplatinum 5 mg/ml ATC: L01XA03
Manufacturer: Fosun Pharma Sp. z o.o.
-
The medicinal product is used in the treatment of colorectal cancer (stage III colon cancer after tumor removal and colorectal cancer with metastases). It is used in combination with other anticancer drugs.
Form: solution for infusion, concentrate
Active substance Dosage oxaliplatinum 5 mg/ml ATC: L01XA03
Manufacturer: Fresenius Kabi Deutschland GmbH
-
The medicinal product is used in the treatment of advanced colorectal cancer (stage III after complete resection of the primary tumor) as well as colon and rectal cancer with metastases.
Form: solution for infusion, concentrate
Active substance Dosage oxaliplatinum 5 mg/ml ATC: L01XA03
Manufacturer: AS Kalceks